Search results
Results from the WOW.Com Content Network
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly.. In a head-to-head comparison of the two GLP-1 drugs ...
They also reported that 31% of people taking Zepbound achieved at least 25% body weight loss compared to 16% for those taking Wegovy. On average, people taking Zepbound lost about 50 pounds, while ...
Zepbound is intended to be used along with a reduced-calorie diet and physical exercise for weight loss, the FDA says. Side effects of Zepbound All medications come with potential side effects ...
While both medications showed a significant weight loss benefit, after 72 weeks on treatment, people treated with Zepbound lost 20% of their body weight, compared to people on Wegovy who lost just ...
Over the course of the entire treatment period of 88 weeks, patients who continued Lilly's drug showed 25.3% weight loss. The overall weight reduction was 9.9% during the entire study period for ...
Like other weight loss drugs, Zepbound is an injection patients give themselves once a week. In the news release, Lilly recommends that the drug be used in combination with a reduced-calorie diet ...
Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk.
Zepbound, made by Eli Lilly, is the newest FDA-approved drug for weight loss. (It was previously a diabetes treatment known as Mounjaro.) FDA Approves Zepbound, the Most Potent Weight Loss Drug Yet